Search research articles
Contact Us
Filters
Showing results (21-30 of 93) with videos related to
Page
of 10
Sort By:
AJNR. American Journal of Neuroradiology
|
July 12, 2024
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with <i>IDH</i>-Mutant Glioma
Lucia Nichelli, Capucine Cadin, Patrizia Lazzari, et al.
Nature Communications
|
November 16, 2018
Microfluidic active loading of single cells enables analysis of complex clinical specimens
Nicholas L Calistri, Robert J Kimmerling, Seth W Malinowski, et al.
Acta Neuropathologica Communications
|
September 9, 2018
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
Romain Appay, Emeline Tabouret, Mehdi Touat, et al.
Neuro-Oncology Practice
|
March 9, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases
Mehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi, et al.
Biorxiv : the Preprint Server for Biology
|
January 16, 2026
RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma
Han Xu, Sungwoon Lee, Felipe Leser, et al.
The Oncologist
|
January 4, 2021
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges
Cristina Birzu, Suzanne Tran, Franck Bielle, et al.
Journal of Neuro-Oncology
|
August 4, 2018
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
Rimas V Lukas, Jordi Rodon, Kevin Becker, et al.
Neuro-Oncology
|
October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort
Domique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Journal of Neuro-Oncology
|
May 16, 2015
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
Marcos A dos Santos, Jean-Pierre Pignon, Pierre Blanchard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2017
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas
Julia Delahousse, Loic Verlingue, Sophie Broutin, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 93) with videos related to
Sort By:
Page
of 10
AJNR. American Journal of Neuroradiology
|
July 12, 2024
Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with <i>IDH</i>-Mutant Glioma
Lucia Nichelli, Capucine Cadin, Patrizia Lazzari, et al.
Nature Communications
|
November 16, 2018
Microfluidic active loading of single cells enables analysis of complex clinical specimens
Nicholas L Calistri, Robert J Kimmerling, Seth W Malinowski, et al.
Acta Neuropathologica Communications
|
September 9, 2018
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome
Romain Appay, Emeline Tabouret, Mehdi Touat, et al.
Neuro-Oncology Practice
|
March 9, 2026
Preserved IDH mutation and methylation class in vorasidenib nonresponders: A report of 2 cases
Mehdi Touat, Jacqueline Lehmann-Che, Salah Eddine O Kacimi, et al.
Biorxiv : the Preprint Server for Biology
|
January 16, 2026
RIG-I RNA agonist activates immunostimulatory macrophages to enhance checkpoint immunotherapy for glioblastoma
Han Xu, Sungwoon Lee, Felipe Leser, et al.
The Oncologist
|
January 4, 2021
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges
Cristina Birzu, Suzanne Tran, Franck Bielle, et al.
Journal of Neuro-Oncology
|
August 4, 2018
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
Rimas V Lukas, Jordi Rodon, Kevin Becker, et al.
Neuro-Oncology
|
October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort
Domique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Journal of Neuro-Oncology
|
May 16, 2015
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival
Marcos A dos Santos, Jean-Pierre Pignon, Pierre Blanchard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2017
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas
Julia Delahousse, Loic Verlingue, Sophie Broutin, et al.
Page
of 10